Found: 6
Select item for more details and to access through your institution.
Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Acinetobacter baumannii-calcoaceticus Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 4, p. 1, doi. 10.1093/ofid/ofae140
- By:
- Publication type:
- Article
A new platform for ultra-high density Staphylococcus aureus transposon libraries.
- Published in:
- BMC Genomics, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12864-015-1361-3
- By:
- Publication type:
- Article
In Vivo Emergence of Pandrug-Resistant Acinetobacter baumannii Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-Durlobactam.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Stable micron-scale holes are a general feature of canonical holins.
- Published in:
- Molecular Microbiology, 2014, v. 91, n. 1, p. 57, doi. 10.1111/mmi.12439
- By:
- Publication type:
- Article
Protein determinants of phage T4 lysis inhibition.
- Published in:
- Protein Science: A Publication of the Protein Society, 2012, v. 21, n. 4, p. 571, doi. 10.1002/pro.2042
- By:
- Publication type:
- Article
Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.709974
- By:
- Publication type:
- Article